GI oncology Clinical Trials in Ann Arbor, MI
As of August 2026, 35 paid clinical trials are recruiting for GI oncology in Ann Arbor, Michigan. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
35 clinical trials for GI oncology
·Clear filters·A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
A Study of PHST001 in Advanced Solid Tumors
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
Study of Safety and Efficacy of RGT-61159 in Adults With Relapsed/Refractory Adenoid Cystic Carcinoma (ACC) or Colorectal Carcinoma (CRC)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
Pancreatic Cancer Early Detection Consortium
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
National Liver Cancer Screening Trial
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Obeticholic Acid for Prevention in Barrett's Esophagus
Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer
CEUS vs. AMRI for HCC Detection in Patients With Indeterminate Liver Nodules
A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients
Testing for Safety and Colorectal Cancer Preventive Effects of ONC201
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
FITting Non-invasive Tests in Lynch Syndrome Surveillance
Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer
The Cancer of the Pancreas Screening-5 CAPS5)Study
A Pilot Study of Liver Protection Using Prednisone for Patients Receiving Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma
A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
Top Research Study Locations in Ann Arbor
Researchers run research studies in Ann Arbor, MI at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of Michigan | Healthy, Heart Failure, Acute Kidney Injury | 389 |
| University of Michigan Rogel Cancer Center | Anatomic Stage II Breast Cancer AJCC v8, Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm | 80 |
| Trinity Health Saint Joseph Mercy Hospital Ann Arbor | Stage IV Lung Cancer AJCC v8, Lung Non-Small Cell Carcinoma, Acute Myeloid Leukemia | 65 |
| C S Mott Children's Hospital | B Acute Lymphoblastic Leukemia, Neuroblastoma, Acute Myeloid Leukemia | 29 |
| University of Michigan Comprehensive Cancer Center | Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Breast Carcinoma | 27 |
| University of Michigan Health System | Chronic Kidney Disease, ADA SCID, Adolescent Congenital Heart Disease | 23 |
| VA Ann Arbor Healthcare System, Ann Arbor, MI | Prostate Cancer, Adult Growth Hormone Deficiency, Alcohol Use Disorder | 23 |
| C.S. Mott Children's Hospital | Diffuse Intrinsic Pontine Glioma, High Grade Glioma, Anaplastic Astrocytoma | 18 |
| University of Michigan Hospital | ARDS, ARDS (Acute Respiratory Distress Syndrome), Acute Respiratory Distress Syndrome | 14 |
| University of Michigan School of Dentistry | Gum Disease, Healing Wound, Dental Diseases | 9 |
| University of Michigan Health | Aortic Stenosis, Breast Reconstruction, Colorectal Adenoma | 8 |
| University of Michigan Hospitals | Propionic Acidemia, Adenoid Cystic Carcinoma, Chromophobe Renal Cell Carcinoma | 8 |
| University of Michigan Medical Center | Liver Transplant, Cutaneous Melanoma, Stage II, Glomerulosclerosis, Focal Segmental | 8 |
| Michigan Medicine | Sleep Apnea, Obstructive, Aging, Alzheimer Disease | 6 |
| University of Michigan Kellogg Eye Center | Cone Rod Dystrophy, Juvenile Macular Degeneration, Stargardt Disease | 6 |
| University of Michigan, Michigan Medicine | Cystic Fibrosis, Cystic Fibrosis (CF), Cystic Fibrosis Pulmonary Exacerbation | 6 |
| CS Mott Children's Hospital | Acute Kidney Injury, Acute Kidney Injury Due to Sepsis, Advanced Solid Tumor | 5 |
| Trinity Health IHA - Obstetrics and Gynecology West Arbor | Ampulla of Vater Carcinoma, Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 | 5 |
| GSK Investigational Site | Gastrointestinal Neoplasms, Multiple Myeloma, Myelofibrosis; Primary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia Myelofibrosis | 4 |
| Saint Joseph Mercy Hospital | Anatomic Stage IV Breast Cancer AJCC v8, Cardiotoxicity, Castration Levels of Testosterone | 4 |
| The University of Michigan | Down Syndrome, Hypertonia, Muscle, Nasal Airway Obstruction | 4 |
| VA Ann Arbor Healthcare System | Cardiovascular Diseases, Castrate-sensitive, Castrate-sensitive Prostate Cancer | 4 |
| University of Michigan Health System - Ann Arbor | Asthma, Plasma Cell Myeloma Refractory, Autoimmune Haemolytic Anaemia | 4 |
| C.S Mott Children's Hospital | Neuroblastoma | 3 |
| Michigan Med University of Michigan | ANCA Associated Vasculitis (AAV), Chronic Myelogenous Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 3 |
Active & Upcoming Studies in Ann Arbor (2026)
Recruiting trials in Ann Arbor grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (280 active studies)
- Arsenic Trioxide to Prevent Relapse in Patients Undergoing Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia or Myelodysplastic Syndrome · Phase 1 · University of Michigan Rogel Cancer Center
- Urine Prostate Screening Integrated With MRI for Early Detection of Prostate Cancer, UPRISE Trial · University of Michigan Rogel Cancer Center
Neurology & pain (76 active studies)
- This Study Evaluates the Use of a Data-driven Lower Limb Exoskeleton Controller for Stroke Rehabilitation. · University of Michigan
- Telerehabilitation for Post-Stroke Hand Function · University of Michigan
Cardiovascular (61 active studies)
- Precision T1D Platform - New Therapies for Cardio-Renal Complications · Phase 2 · Oregon Health and Science University
- Mobile Health Intervention to Increase Activity in Heart Failure Study · University of Michigan
Diabetes & metabolic (26 active studies)
- Precision T1D Platform - New Therapies for Cardio-Renal Complications · Phase 2 · Oregon Health and Science University
- Leveraging Interventions for Needs and Knowledge in Diabetes (LINKD) · University of Michigan
Mental health & behavior (23 active studies)
- Informing Implementation of a Circadian-Focused Intervention for Postpartum Depression · University of Michigan
- ALTO-207 in Adults With Treatment-resistant Depression (TRD) · Phase 2 · Alto Neuroscience
Pediatric (15 active studies)
- A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction · Phase 3 · Bayer
- A Pragmatic Clinical Trial of the WE BEAT Well-Being Education Program in Adolescent Congenital Heart Disease: WE BEAT CHD Study · Carelon Research
Eye & vision (10 active studies)
- Study of Serine Supplementation to Protect Vision in MacTel · Phase 3 · The Lowy Medical Research Institute Limited
- A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults · Astellas Pharma Global Development, Inc.
HIV / STI (5 active studies)
- A Self-administered PrEP Decisional Aid for Dissemination With HIV Self-test Kits (DASH) · University of Michigan
- National Liver Cancer Screening Trial · Phase 4 · University of Texas Southwestern Medical Center
Vaccines (4 active studies)
- A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised · Phase 3 · Pfizer
- KIDney Injury in Times of COVID-19 (KIDCOV) · University of California, San Francisco
Common conditions studied in Ann Arbor
- Heart Failure (10 active studies)
- Malignant Solid Neoplasm (10 active studies)
- Obesity (10 active studies)
- Stroke (10 active studies)
- Advanced Solid Tumor (9 active studies)
- Prostate Cancer (9 active studies)
Leading research sponsors in Ann Arbor
- University of Michigan
- University of Michigan Rogel Cancer Center
- National Cancer Institute (NCI)
- VA Office of Research and Development
- Children's Oncology Group
Frequently asked questions
How many paid clinical trials are currently recruiting in Ann Arbor?
There are approximately 970 recruiting clinical trials in Ann Arbor, Michigan listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Ann Arbor pay participants?
Most recruiting trials in Ann Arbor compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Ann Arbor?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Ann Arbor?
The most common conditions under active study in Ann Arbor include Heart Failure (10), Malignant Solid Neoplasm (10), Obesity (10), Stroke (10), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Ann Arbor?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Ann Arbor on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Ann Arbor?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Ann Arbor?
Recruiting research sites in Ann Arbor include University of Michigan, University of Michigan Rogel Cancer Center, Trinity Health Saint Joseph Mercy Hospital Ann Arbor, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Ann Arbor right now?
The largest active categories in Ann Arbor are Cancer & tumors (280), Neurology & pain (76), Cardiovascular (61). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.